South Africa Reboots Tobacco Control Act: Planning to Unify the Package of Vapes

Regulations by 2FIRSTS.ai
Aug.14.2024
South Africa Reboots Tobacco Control Act: Planning to Unify the Package of Vapes
South Africa's Tobacco Control and Electronic Delivery Systems Bill has been reintroduced by parliament, aiming to enhance public health measures.

According to BusinessTech's report on August 13th, the South African "Tobacco Products Control and Electronic Delivery Systems Bill" has been revived by Parliament after lapsing at the end of the previous government's term, and has now entered the further processing stage. The bill was first introduced in December 2022 in the National Assembly and has now been included in the agenda of the seventh government.


According to reports, the proposed bill aims to strengthen public health protection measures by aligning current smoking control legislation with the requirements of the World Health Organization's Framework Convention on Tobacco Control. The legislation under consideration would regulate the sale, advertising, and use of tobacco products and electronic delivery systems. Specific provisions include:


Strengthening the standards for the processing, manufacturing, and importing of products and related products.


Regulate advertising of tobacco products and electronic delivery systems.


Standardizing the packaging and appearance of tobacco and electronic delivery system products.


Smoking is prohibited in all indoor public areas and "designated outdoor areas.


Prohibition of cigarette vending machines.


Mandatory adoption of "simplified packaging with graphic health warnings";


It is prohibited to display tobacco products and electronic delivery systems at retail locations.


The reintroduction of this bill has provoked mixed reactions. Dr. Sharon Nyatsanza of the National Coalition Against Smoking (NCAS) stated that this legislation is an important step towards promoting a healthier society. She said:


By aligning domestic legislation with global standards, a strong tobacco control policy is crucial in reducing the burden of non-communicable diseases in South Africa and supporting the sustainable implementation of national health insurance. The measures in this bill will help reduce tobacco use, exposure to secondhand smoke, and youth smoking.


Dr. Catherine Egbe, head of the Global Adult Tobacco Survey in South Africa (GATS-SA), emphasized the need to pass the bill as soon as possible.


According to GATS-SA data, 29.4% of individuals aged 15 and over, totaling 12.7 million people, are using tobacco, facing serious health risks such as cancer, cardiovascular diseases, and respiratory diseases. The phenomenon of adolescents using e-cigarettes is also on the rise, raising concerns about nicotine addiction and long-term health effects, especially on the developing brains of young people.


Dr. Egbe stated that the proposed measures in the bill are an effective strategy to reduce tobacco and e-cigarette use, and should be urgently implemented, along with an increase in taxes.


Our government has access to all the research that can support every evidence-based measure in the bill and should not be influenced by misleading information.


It has been reported that the National Assembly Health Committee, a former parliamentary subcommittee, had called for written submissions on the bill. A nationwide public hearing subsequently ended in December 2023. Throughout this process, media statements from the committee largely indicated broad principle support for the bill's health-related objectives. However, there are still many pressing issues to be addressed at the operational level. These include:


The likelihood of an increase in illicit tobacco product trade.


The potential decrease in tax revenue from the production and sale of legal tobacco products and electronic delivery systems;


There is insufficient attention given to the impact on small and medium-sized informal traders, especially retailers of single cigarette sales.


Monitoring and enforcement capabilities are inadequate.


Despite the prevalence of the cigarette market in South Africa, illegal trade is rapidly growing. Opponents of the legislation believe that such laws could further fuel the development of the illegal market.


The South African Legal Academy (SA Legal Academy) mentioned:


Given these issues, it is currently unclear how the new National Assembly Health Committee will address them.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
According to Interfax-Ukraine, a study conducted by market research firm Kantar Ukraine at the request of major tobacco companies found that more than 93% of vape products in Ukraine did not fully comply with regulatory requirements. The research examined product categories, brand distribution and consumer purchasing channels, showing that pod systems and disposable vapes represent major segments of the market, while offline retail remains the dominant purchasing channel. The findings highlight ongoing compliance challenges in Ukraine’s vape market.
Aug.26
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Product | KIWI Launches Spark 2 and Spark 2 Pro in Germany, Two Hardware Tiers Share Backward-Compatible 2ml Pods
Product | KIWI Launches Spark 2 and Spark 2 Pro in Germany, Two Hardware Tiers Share Backward-Compatible 2ml Pods
KIWI has launched the Spark 2 and Spark 2 Pro refillable pod systems in Germany at official prices of €18 and €29, respectively. Spark 2 uses an 800mAh removable lithium-ion battery in a pen-style body, while Spark 2 Pro features a 1,400mAh removable battery, a box-shaped design and vibration feedback every 20 puffs. Both devices use the same 2ml Spark V2 pods in 0.8Ω and 1.2Ω versions, with AirSync airflow adjustment and a choice between Cotton Tips and conventional Drip Tips. The new pods also remain compatible with the original KIWI Spark.
News
Sep.29 by 2Firsts Perspectives
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10